Dr. Aleksandra A Wianecka, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 66 Deer Park Ave, Babylon, NY 11702 Phone: 631-789-6103 Fax: 631-789-6105 |
David Worksman Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 66 Deer Park Ave, Babylon, NY 11702 Phone: 631-669-3757 Fax: 631-669-3022 |
Slj Lion Express Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 135 Deer Park Ave, Babylon, NY 11702 Phone: 516-915-0102 |
Vision For Life Corp Optometrist Medicare: Medicare Enrolled Practice Location: 66 Deer Park Ave, Babylon, NY 11702 Phone: 631-789-6103 Fax: 631-789-6105 |
Dr. Theresa Maria Rua, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 W Main St, Suite210, Babylon, NY 11702 Phone: 631-957-3355 Fax: 631-991-6703 |
Dr. Michael Lamonica, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 W Main St, #210, Babylon, NY 11702 Phone: 631-957-3355 Fax: 631-957-4378 |
Dr. Elaine Bouras Optometrist Medicare: Accepting Medicare Assignments Practice Location: 40 E Main St, Babylon, NY 11702 Phone: 631-587-2020 |
Jaclyn Benzoni Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 40 E Main St, Babylon, NY 11702 Phone: 631-587-2020 Fax: 631-587-2087 |
News Archive
Aging published "Cdkn1a transcript variant 2 is a marker of aging and cellular senescence" which reported that cellular senescence is a cell fate response characterized by a permanent cell cycle arrest driven primarily the by cell cycle inhibitor and tumor suppressor proteins p16Ink4a and p21Cip1/Waf1.
The Atlantic looks at the challenges facing the passage of I-VAWA (S.2982, HR. 4594), or the International Violence Against Women Act, which was recently delayed in Congress.
Cardialysis and Sticares InterACT, both Contract Research Organizations (CROs) headquartered in The Netherlands, announced today that they have entered into a strategic collaboration to provide drug development consulting services in the field of cardiovascular and metabolic medicine. Both organizations have substantial experience and success in the execution of clinical research projects for pharmaceutical, biotechnology and medical device companies.
"Thirty years after the first treaty on women's rights was adopted by the United Nations, millions of cases involving beatings, marital rapes, honor killings and genital mutilation lead to deaths, medical injuries, failed pregnancies, abortions and psychological damage," according to a GlobalPost article that reports on the rising number of individuals, communities and governments worldwide committing to end violence against women.
By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.
› Verified 3 days ago